Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes

European Journal of Immunology

Volumn 32, Issue 9, 2002, Pages 2644-2652

  Van Baalen, Carel A ^a,d   Guillon, Christophe ^a   Van Baalen, Minus ^b   Verschuren, Esther J ^a   Boers, Patrick H M ^a   Osterhaus, Albert D M E ^a   Gruters, Rob A ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITÉ DE LYON   (France)

^d UPMC University Paris 06   (France)

Author keywords

AIDS; Cell mediated immunity; Mathematical model; Viral regulatory protein; Virus replication

Indexed keywords

CD4 ANTIGEN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; REGULATOR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RESISTANCE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; TARGET CELL; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, NEF; GENE PRODUCTS, REV; HIV ANTIGENS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; KINETICS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 0036737605     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R     Document Type: Article

References (45)

1. + cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 1997. 66: 273-311.
2. McMichael, A. J. and Rowland-Jones, S. L., Cellular immune responses to HIV. Nature 2001. 410: 980-987.
3. Klein, M. R., Van der Burg, S. H., Pontesilli, O. and Miedema, F., Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox? Immunol. Today 1998. 19: 317-324.
4. Soudeyns, H. and Pantaleo, G., The moving target: mechanisms of HIV persistence during primary infection. Immunol. Today 2000. 20: 446-450.
5. van Baalen, C. A., Pontesilli, O., Huisman, R. C., Geretti, A. M., Klein, M. R., De Wolf, F., Miedema, F., Gruters, R. A. and Osterhaus, A. D. M. E., Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J. Gen. Virol. 1997. 78: 1913-1918.
6. Geretti, A. M., Hulskotte, E. G., Dings, M. E., van Baalen, C. A., van Amerongen, G., Norley, S. G., Boers, P. H., Gruters, R. A. and Osterhaus, A. D. M. E., Decline of Simian Immunodeficiency Virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5. J. Infect. Dis. 1999. 180: 1133-1141.
7. Allen, T. M., O'Connor, D. H., Jing, P., Dzuris, J. L., Mothe, B. R., Vogel, T. U., Dunphy, E., Liebl, M. E., Emerson, C., Wilson, N., Kunstman, K. J., Wang, X., Allison, D. B., Hughes, A. L., Desrosiers, R. C., Altman, J. D., Wolinsky, S. M., Sette, A. and Watkins, D. I., Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000. 407: 386-390.
8. Pantaleo, G., Demarest, J. F., Schacker, T., Vaccarezza, M., Cohen, O. J., Daucher, M., Graziosi, C., Schnittman, S. S., Quinn, T. C., Shaw, G. M., Perrin, L., Tambussi, G., Lazzarin, A., Sekaly, R. P., Soudeyns, H., Corey, L. and Fauci, A. S., The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA 1997. 94: 254-258.
9. Harrer, T., Harrer, E., Kalams, S. A., Barbosa, P., Trocha, A., Johnson, R. P., Elbeik, T., Feinberg, M. B., Buchbinder, S. P. and Walker, B. D., Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: Breath and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 1996. 156: 2616-2623.
10. Altfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., Sax, P. E., Boswell, S., Kahn, J. O., Brander, C., Goulder, P. J., Levy, J. A., Mullins, J. I. and Walker, B. D., Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 2001. 193: 169-180.
11. Derby, M. A., Alexander-Miller, M. A., Tse, R. and Berzofsky, J. A., High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 2001. 166: 1690-1697.
12. Reddehase, M. J., The immunogenicity of human and murine cytomegaloviruses. Curr. Opin. Immunol. 2000. 12: 390-396.
13. Ranki, A., Lagerstedt, A., Ovod, V., Aavik, E. and Krohn, K. J., Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 1994. 139: 365-378.
14. Kim, S., Byrn, R., Groopman, J. and Baltimore, D., Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J. Virol. 1989. 63: 3708-3713.
15. Klotman, M. E., Kim, S., Buchbinder, A., DeRossi, A., Baltimore, D. and Wong-Staal, F., Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 1991. 88: 5011-5015.
16. Guatelli, J. C., Gingeras, T. R. and Richman, D. D., Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J. Virol. 1990. 64: 4093-4098.
17. + cells. Virology 1996. 225: 248-253.
18. Yang, O. O., Kalams, S. A., Rosenzweig, M., Trocha, A., Jones, N., Koziel, M., Walker, B. D. and Johnson, R. P., Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 1996. 70: 5799-5806.
19. + cells: evidence for HLA class I-restricted triggering of cytolytic and non-cytolitic mechanisms. J. Virol. 1997. 71: 3120-3128.
20. + T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes. J. Virol. 2000. 74: 6695-6699.
21. Guillon, C., van Baalen, C. A., Boers, P. H. M., Verschuren, E. J., Gruters, R. A. and Osterhaus, A. D. M. E., Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef. J. Virol. Methods 2002. 99: 115-121.
22. Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L-J., Blumenthal, R. and Martin, M. A., Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 1993. 67: 2182-2190.
23. Klenerman, P., Phillips, R. E., Rinaldo, C. R., Wahl, L. M., Ogg, G., May, R. M., McMichaél, A. J. and Nowak, M. A., Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl. Acad. Sci. USA 1996. 93: 15323-15328.
24. Little, S. J., McLean, A. R., Spina, C. A., Richman, D. D. and Havlir, D. V., Viral dynamics of acute HIV-1 infection. J. Exp. Med. 1999. 190: 841-850.
25. Johnson, R. P., Trocha, A., Buchanan, T. M., and Walker, B. D., Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: Definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 1992. 175: 961-971.
26. van Baalen, C. A., Schutten, M., Huisman, R. C., Boers, P. H. M., Gruters, R. A. and Osterhaus, A. D. M. E., Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J. Virol. 1998. 72: 6851-6857.
27. Zinkernagel, R. M. and Althage, A., Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J. Exp. Med. 1977. 145: 644-651.
28. Ehl, S., Klenerman, P., Aichele, P., Hengartner, H. and Zinkernagel, R. M., A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 1997. 27: 3404-3413.
29. Klein, M. R., Van der Burg, S. H., Keet, I. P., Hovenkamp, E., Holwerda, A. M., Drijfhout, J. W., Melief, C. J. and Miedema, F., Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J. Gen. Virol 1998. 79: 2191-2201.
30. Tsomides, T. J., Aldovini, A., Johnson, R. P., Walker, B. D., Young, R. A. and Eisen, H. N., Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 1994. 180: 1283-1293.
31. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. and Baltimore, D., HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998. 391: 397-401.
32. Pontesilli, O., Klein, M. R., Kerkhof-Garde, S. R., Pakker, N. G., De Wolf, F., Schuitemaker, H. and Miedema, F., Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J. Infect. Dis. 1998. 178: 1008-1018.
33. Haas, G., Plikat, U., Debre, P., Lucchiari, M., Katlama, C., Dudoit, Y., Bonduelle, O., Bauer, M., Ihlenfeldt, H. G., Jung, G., Maier, B., Meyerhans, A. and Autran, B., Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 1996. 157:4212-4221.
34. Pierson, T., McArthur, J. and Siliciano, R. F., Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 2000. 18: 665-708.
35. Tenner-Racz, K. and Racz, P., Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficiency virus. Curr. Top. Microbiol. Immunol. 1995. 201: 141-159.
36. Gruters, R. A., van Baalen, C. A. and Osterhaus, A. D. M. E., The advantage of early recognition of HIV infected cells by cytotoxic T lymphocytes. Vaccine 2002. 20: 2011-2015.
37. Osterhaus, A. D. M. E., van Baalen, C. A., Gruters, R. A., Schutten, M., Siebelink, C. H. J., Hulskotte, E. G. J., Tijhaar, E. J., Randall, R. E. R., van Amerongen, G., Fleuchaus, A., Erfle, V. and Sutter, G., Vaccination with Rev and Tat against AIDS. Vaccine 1999. 17: 2713-2714.
38. Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M. T., Goletti, D., Baroncelli, S., Pace, M., Sernicola, L., Koanga-Mogtomo, M. L., Betti, M., Borsetti, A., Belli, R., Akerblom, L., Corrias, F., Butto, S., Heeney, J., Verani, P., Titti, F. and Ensoli, B., Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med. 1999. 5: 643-650.
39. Pauza, C. D., Trivedi, P., Wallace, M., Ruckwardt, T. J., Le Buanec, H., Lu, W., Bizzini, B., Burny, A., Zagury, D. and Gallo, R. C., Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. USA 2000. 97: 3515-3519.
40. Stittelaar, K. J., Gruters, R. A., Schutten, M., van Baalen, C. A., van Amerongen, G., Cranage, M., Liljeström, P., Sutter, G. and Osterhaus, A. D. M. E., Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine 2002. 20: 2921-2927.
41. Groenink, M., Fouchier, R. A. M., De Goede, R. E. Y., De Wolf, F., Cuypers, H. T. M., Gruters, R. A., Huisman, H. G. and Tersmette, M., Phenotypical heterogeneity in a panel of infectious molecular HIV-1 clones derived from a single individual. J. Virol. 1991. 65: 1968-1975.
42. Guillon, C., Bedin, F., Fouchier, R. A., Schuitemaker, H. and Gruters, R. A., Completion of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patient. AIDS Res. Hum. Retroviruses 1995. 11: 1537-1541.
43. Guillon, C., Oriol, G. and Gruters, R. A., Molecular characterization of HIV viruses generated after in vivo ligation. J. Virol. Methods 1997. 66: 237-246.
44. Philpott, N. J., Turner, A. J., Scopes, J., Westby, M., Marsh, J. C., Gordon-Smith, E. C., Dalgleish, A. G. and Gibson, F. M., The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 1996. 87: 2244-2251.
45. Gurney, W. S. C. and Nisbet, R. M., The systematic formulation of delay differential models of age or size structured populations. In Freedman, H. I. and Strobeck, C. (Eds.) Population Biology. Lecture Notes in Biomathematics. Springer, Berlin 1983, pp 163-172.